Agree.
It’s how it works! Always read the fine print.
Nearly 5 months later!
Has MXC received the TGA approval? Rhetorical question.
From 27-Aug-2018
“In partnership with the Institute for Health Research at the University of Notre Dame, MXC received Human Research Ethics Committee approval to conduct a Phase II clinical trial into the benefits of CogniCannTM in Dementia and Alzheimer patients.”
“Subject to Australia’s Therapeutic Goods Administration (TGA) approval, the 16-week, randomised, double-blind, crossover, placebo-control trial is expected to start early next year.”
Dementia / CogniCann, page-28
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.065(39.4%) |
Mkt cap ! $11.13M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 23.0¢ | 17.5¢ | $97.37K | 451.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 6921 | 5 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |